CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Multiplexing Prismdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06027216
NCT06027216N/ACompleted

Monocular Visual Confusion for Field Expansion

Massachusetts Eye and Ear Infirmary·interventional·Posted Sep 7, 2023·Updated May 8, 2025

In Brief

A clinical study evaluating Multiplexing Prism for One Eye Blindness and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators are testing a simplified design and fitting protocol to provide field expansion for individuals with acquired monocular vision.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedSep 7, 2023
Enrollment StartDec 27, 2023
Primary CompletionOct 22, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.8 years ago

Interventions

Multiplexing Prismdevice

Multiplexing prism is designed for spatial vision multiplexing. It allows partial light transmission through the prism allow the observer to simultaneously see the physical world through the prism and see the "shifted view" from the non-seeing side. It is developed to expand the field of view of individuals with just one eye.